Ambalavanan R, Snead R, Marczika J, Malioukis A
Front Public Health. 2024; 12:1347623.
PMID: 38414904
PMC: 10896918.
DOI: 10.3389/fpubh.2024.1347623.
Mullineaux J, Leurent B, Jendoubi T
J Transl Med. 2023; 21(1):848.
PMID: 38001532
PMC: 10668378.
DOI: 10.1186/s12967-023-04436-5.
Lim L, Lim H, Liew M, Chen W
J Asthma Allergy. 2023; 16:1207-1216.
PMID: 37927777
PMC: 10625321.
DOI: 10.2147/JAA.S425342.
Zhan Q
Med Rev (2021). 2023; 1(1):2.
PMID: 37724078
PMC: 10388774.
DOI: 10.1515/mr-2021-0030.
Knecht W, Fisher S, Lou J, Sele C, Ma S, Andersson Rasmussen A
Int J Mol Sci. 2023; 24(17).
PMID: 37686452
PMC: 10563069.
DOI: 10.3390/ijms241713649.
Development and external validation of a mixed-effects deep learning model to diagnose COVID-19 from CT imaging.
Bridge J, Meng Y, Zhu W, Fitzmaurice T, McCann C, Addison C
Front Med (Lausanne). 2023; 10:1113030.
PMID: 37680621
PMC: 10481527.
DOI: 10.3389/fmed.2023.1113030.
Communicating science in the COVID-19 news in the UK during Omicron waves: exploring representations of nature of science with epistemic network analysis.
Cheung K, Chan H, Erduran S
Humanit Soc Sci Commun. 2023; 10(1):282.
PMID: 37305352
PMC: 10240474.
DOI: 10.1057/s41599-023-01771-2.
The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment.
Wang M, Zhang Y, Li C, Chang W, Zhang L
Front Immunol. 2023; 14:1180336.
PMID: 37205106
PMC: 10185909.
DOI: 10.3389/fimmu.2023.1180336.
Risk factors for severe Covid-19 breakthrough infections: an observational longitudinal study.
Ben Fredj S, Ghammem R, Zammit N, Maatouk A, Haddad N, Haddad N
BMC Infect Dis. 2022; 22(1):894.
PMID: 36443699
PMC: 9706846.
DOI: 10.1186/s12879-022-07859-5.
Comparison of COVID-19 survival in relation to CPAP length of treatment and by comorbidity and transmission setting (community or hospital acquired) in a medium-sized UK hospital in 2020: a retrospective study.
Sedda L, Ashish A, Unsworth A, Martindale J, Sundar R, Farrier M
BMJ Open. 2022; 12(11):e060994.
PMID: 36414291
PMC: 9684282.
DOI: 10.1136/bmjopen-2022-060994.
Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity.
Santer D, Li D, Ghosheh Y, Zahoor M, Prajapati D, Hansen B
Nat Commun. 2022; 13(1):6992.
PMID: 36385011
PMC: 9667439.
DOI: 10.1038/s41467-022-34709-4.
Utility of illness symptoms for predicting COVID-19 infections in children.
Zhou G, Penwill N, Cheng G, Singh P, Cheung A, Shin M
BMC Pediatr. 2022; 22(1):655.
PMID: 36357876
PMC: 9647749.
DOI: 10.1186/s12887-022-03729-w.
Application of neighborhood-scale wastewater-based epidemiology in low COVID-19 incidence situations.
Oh C, Zhou A, OBrien K, Jamal Y, Wennerdahl H, Schmidt A
Sci Total Environ. 2022; 852:158448.
PMID: 36063927
PMC: 9436825.
DOI: 10.1016/j.scitotenv.2022.158448.
Randomised trial to determine the effect of vitamin D and zinc supplementation for improving treatment outcomes among patients with COVID-19 in India: trial protocol.
Sharma K, Partap U, Mistry N, Marathe Y, Wang M, Shaikh S
BMJ Open. 2022; 12(8):e061301.
PMID: 36038172
PMC: 9437735.
DOI: 10.1136/bmjopen-2022-061301.
Seroprevalence of SARS-COV-2 antibodies among health-care workers exposed to COVID-19 patients in a large reference hospital, Iran.
Pagheh A, Asghari A, Abrari Romenjan K, Mousavi T, Abedi F, Ziaee A
Iran J Microbiol. 2022; 14(2):138-144.
PMID: 35765550
PMC: 9168247.
DOI: 10.18502/ijm.v14i2.9178.
Vitamin D: A Potential Mitigation Tool for the Endemic Stage of the COVID-19 Pandemic?.
Noriega D, Savelkoul H
Front Public Health. 2022; 10:888168.
PMID: 35757617
PMC: 9226430.
DOI: 10.3389/fpubh.2022.888168.
From Pandemicity to Endemicity: The Journey of SARS-CoV-2.
Al-Tawfiq J, Chu D, Hoang V, Memish Z
J Epidemiol Glob Health. 2022; 12(2):147-149.
PMID: 35704175
PMC: 9198624.
DOI: 10.1007/s44197-022-00046-4.
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants.
Iaconis D, Bordi L, Matusali G, Talarico C, Manelfi C, Cesta M
Cell Death Dis. 2022; 13(5):498.
PMID: 35614039
PMC: 9130985.
DOI: 10.1038/s41419-022-04961-z.
What Happened Next? The Experiences of Postsecondary Students With Disabilities as Colleges and Universities Reconvened During the Pandemic.
Madaus J, Faggella-Luby M, Dukes 3rd L, Gelbar N, Langdon S, Tarconish E
Front Psychol. 2022; 13:872733.
PMID: 35602703
PMC: 9119413.
DOI: 10.3389/fpsyg.2022.872733.
Factors associated with the opposition to COVID-19 vaccination certificates: A multi-country observational study from Asia.
Kc S, Faradiba D, Sittimart M, Isaranuwatchai W, Ananthakrishnan A, Rachatan C
Travel Med Infect Dis. 2022; 48:102358.
PMID: 35595199
PMC: 9113761.
DOI: 10.1016/j.tmaid.2022.102358.
